Posted by Anne Hermann on Wed, Apr 25, 2012 @ 02:07 PM
Low Dose Naltrexone, or LDN, is a small dose of a medication called Naltrexone that was FDA approved for treatment in opiod addiction in 1984. Naltrexone is believed to increase our body’s production of endorphins, which boosts the immune system.
Within a year of hitting the market, some physicians noticed that very low doses of naltrexone reduced decline rates in HIV and cancer patients.
Currently, multiple research centers, including Stanford, Penn State University, University of California, San Francisco and University of Utah performed small studies that demonstrate that LDN is beneficial for:
- Multiple Sclerosis
- Chronic Fatigue Syndrome
- Crohn’s Disease
- Autoimmune skin disorders
- Ovarian cancer
- Pancreatic cancer
In general, LDN is safe and tolerated very well. It may enhance treatment of many autoimmune diseases. While studies are small, they are all positive and since the medication is safe, it can make a big difference to a lot of people.
Anne Hermann, MD is double board certified in Internal Medicine and as a Physician Nutrition Specialist. To schedule your consult, please call (813) 902-9559.
This post was written by Anne Hermann. Follow Anne Hermann on Google, Facebook, Twitter & Linkedin.